REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Symbio-Lab Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Toilet Preparation Manufacturing | All Other Chemical Product and Preparation Manufacturing | Chemical and Allied Products Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Cosmetics, Beauty Supplies, and Perfume Stores | Electronic Shopping and Mail-Order Houses | Other Direct Selling Establishments | Services to Buildings and Dwellings
Full name: Symbio-Lab Sp. z o.o. Profile Updated: April 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Symbio-Lab Sp. z o.o. is a company based in Poland, with its head office in Krosno. The company operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on January 20, 2012. It currently has a total number of 1 (2015) employees. From the latest financial highlights, Symbio-Lab Sp. z o.o. reported a net sales revenue increase of 39.69% in 2023. Over the same period, its total assets grew by 38.36%.

Headquarters
Ul. Lelewela 12/29
Krosno; Podkarpackie; Postal Code: 38-400

Contact Details: Purchase the Symbio-Lab Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Symbio-Lab Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Symbio-Lab Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Symbio-Lab Sp. z o.o. report to view the information.
Incorporation Date:
January 20, 2012
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
65%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Symbio-Lab Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
39.69%▲
Total operating revenue
44.91%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
38.36%▲
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
-23.43%▼
Debt to Equity Ratio
N/A
Quick Ratio
0.5%▲
Cash Ratio
0.14%▲

Similar companies

Adamed Pharma S.A.
 
"Przedsiebiorstwo Produkcji Farmaceutycznej Hasco - Lek" S.A.
Tarchominskie Zaklady Farmaceutyczne "Polfa" S.A.
 
Ziaja Ltd Zaklad Produkcji Lekow Sp. z o.o.
Maco Productions Polonia Sp. z o.o.
 
Orifarm Manufacturing Poland Sp. z o.o.
Life Solutions Sp. z o.o.
 
Syntalpharma Sp. z o.o.
Health Works Sp. z o.o.
 
Pharma Innovations Sp. z o.o.
"Medicplast Polska" Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo